Literature DB >> 15115687

Biochemical study on beta-glucosidase in individuals with Gaucher's disease and normal subjects.

Kristiane Michelin1, Alessandro Wajner, Laureci da S Goulart, Angela A Fachel, Maria Luiza S Pereira, Alexandre S de Mello, Fernanda T S Souza, Ricardo F Pires, Roberto Giugliani, Janice C Coelho.   

Abstract

BACKGROUND: Gaucher's disease (GD) is a disorder caused by the deficiency of lysosomal beta-glucosidase, an enzyme that participates in the degradation of glycosphingolipids. Deficiency of this enzyme results in the accumulation of glucocerebrosides in macrophage lysosomes. No studies comparing the biochemical and kinetic behavior of this enzyme in leukocytes and fibroblasts from normal individuals and patients with Gaucher's disease are available.
METHODS: We compared the activities of beta-glu and chitotriosidase between normal subjects and Gaucher disease patients, and characterized the behavior of beta-glu in terms of pH optimum, heat stability, Km and Vmax.
RESULTS: The results showed a different behavior of the enzyme in the groups analyzed.
CONCLUSIONS: This finding might be useful in cases in which the measurement of enzyme activity alone is not reliable for the establishment of the diagnosis of Gaucher's disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15115687     DOI: 10.1016/j.cccn.2004.01.010

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  3 in total

Review 1.  Type 2 Gaucher disease: phenotypic variation and genotypic heterogeneity.

Authors:  N Gupta; I M Oppenheim; E F Kauvar; N Tayebi; E Sidransky
Journal:  Blood Cells Mol Dis       Date:  2010-09-28       Impact factor: 3.039

2.  Novel stereoselective syntheses of N-octyl-β-valienamine (NOV) and N-octyl-4-epi-β-valienamine (NOEV) from (-)-shikimic acid.

Authors:  Feng-Lei Li; Jiang-Ping Yu; Wei Ding; Mian-Mian Sun; Yun-Gang He; Xing-Liang Zhu; Shi-Ling Liu; Xiao-Xin Shi
Journal:  RSC Adv       Date:  2019-12-18       Impact factor: 4.036

3.  Synthesis of Novel Derivatives of 5,6,7,8-Tetrahydroquinazolines Using α-Aminoamidines and In Silico Screening of Their Biological Activity.

Authors:  Arsenii D Snizhko; Alexander V Kyrychenko; Eugene S Gladkov
Journal:  Int J Mol Sci       Date:  2022-03-29       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.